The FDA has granted Philips 510(k) clearance for its ultrasound systems to be used to address lung and cardiac complications that arise in COVID-19 patients. The clearance encompasses the firm’s EPIQ series, Affiniti series, Lumify, CX50 and Sparq diagnostic ultrasounds, and for offerings such as the QLAB Advanced Quantification Software (Read more...)